Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 6 of 6
Full-Text Articles in Medicine and Health Sciences
Evaluation Of Cardiovascular Changes In Patients With Gastric Wall Fat Halo Sign, Ali̇ Küpeli̇, Eser Bulut, Edhem Ünver, Gürkan Danişan
Evaluation Of Cardiovascular Changes In Patients With Gastric Wall Fat Halo Sign, Ali̇ Küpeli̇, Eser Bulut, Edhem Ünver, Gürkan Danişan
Turkish Journal of Medical Sciences
Background/aim: This study aims to investigate the relationship between gastric wall fat halo sign and potentially associated cardiovascular disease (CVD) in thoracic computed tomography (CT). Materials and methods: Between October 2020 and January 2021, 62 patients with gastric wall fat halo sign and 62 controls were evaluated with thorax CT. Patient's height, weight, body mass index (BMI), sex, age, comorbidities, laboratory parameters, diameters of cardiac axes, aorta and pulmonary artery; aorta and coronary artery calcium scores were recorded for the two groups. Results: No significant differences were found in sex, age, height, body weight or BMI between the two groups …
The Visceral Adiposity Index, Lipid Accumulation Product, And Plasma Atherogenicindex Are Associated With Subclinical Atherosclerosis In Patients With Newly Diagnosedacromegaly, Mustafa Özbek, Murat Çalapkulu, Sema Hepşen, Muhammed Erkam Sencar, Hayri̇ Bostan, İlknur Öztürk Ünsal, Erman Çakal
The Visceral Adiposity Index, Lipid Accumulation Product, And Plasma Atherogenicindex Are Associated With Subclinical Atherosclerosis In Patients With Newly Diagnosedacromegaly, Mustafa Özbek, Murat Çalapkulu, Sema Hepşen, Muhammed Erkam Sencar, Hayri̇ Bostan, İlknur Öztürk Ünsal, Erman Çakal
Turkish Journal of Medical Sciences
Background /aim: Acromegaly is a rare chronic endocrine disorder, the active form of which is associated with an increased risk of cardiovascular and metabolic disease. Therefore, early diagnosis and treatment of cardiovascular diseases in acromegaly patients are important in terms of morbidity and mortality. The aim of this study was to determine whether the visceral adiposity index (VAI), lipid accumulation product (LAP), and plasma atherogenic index (PAI) are early cardiovascular risk markers in patients with active acromegaly. Materials and methods: The study included 45 patients newly diagnosed with acromegaly and 45 age-sex matched healthy control subjects. The VAI, LAP, and …
Plasma Thrombin-Activatable Fibrinolysis Inhibitor (Tafi) Antigen Levels In Acromegaly Patients In Remission, Mehmet Erdoğan, Mustafa Özbek, Erdem Akbal, Kemal Üreten
Plasma Thrombin-Activatable Fibrinolysis Inhibitor (Tafi) Antigen Levels In Acromegaly Patients In Remission, Mehmet Erdoğan, Mustafa Özbek, Erdem Akbal, Kemal Üreten
Turkish Journal of Medical Sciences
Background/aim: Acromegaly is associated with increased morbidity andmortality, mostly due to cardiovascular complications.Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels are associated with coagulation/fibrinolysis and inflammation. Plasma TAFI may play a role in arterial thrombosis in cardiovascular diseases. In this study, it was aimed to evaluate the thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and homocysteine levels in patients with acromegaly and healthy control subjects.Materials and methods: Plasma TAFI antigen and homocysteine levels in 29 consecutive patients with acromegaly and 26 age-matched healthy control subjects were measured. All patients included in the study were in remission. The TAFIa/ai antigen in the plasma samples …
The Relationship Of Breast Arterial Calcification Detected In Mammographic Examinations With Cardiovascular Diseases, Cardiovascular Risk Factors, Parity, And Breastfeeding, Kadi̇han Yalçin Şafak, Ayşegül Eratalay, Ebru Dülger İli̇ş, Nesli̇han Umarusman Tanju, Begüm Damla Şencan, Tamer Baysal
The Relationship Of Breast Arterial Calcification Detected In Mammographic Examinations With Cardiovascular Diseases, Cardiovascular Risk Factors, Parity, And Breastfeeding, Kadi̇han Yalçin Şafak, Ayşegül Eratalay, Ebru Dülger İli̇ş, Nesli̇han Umarusman Tanju, Begüm Damla Şencan, Tamer Baysal
Turkish Journal of Medical Sciences
Background/aim: We aimed to detect the incidence of breast arterial calcification (BAC) in patients that underwent mammography and to reveal the relationship of BAC with cardiovascular diseases, cardiovascular risk factors, parity, and breastfeeding. Materials and methods: A total of 1195 female patients were included in this study. Cases that were positive for BAC during mammography were recorded. The relationship of BAC with age, body mass index, parity, breastfeeding, menopause, smoking, alcohol consumption, oral contraceptive use, hormone replacement therapy, and histories of hypertension (HT), diabetes mellitus (DM), coronary artery disease (CAD), and cerebral vascular diseases were investigated. Results: Overall, 97 of …
Could Obstructive Sleep Apnea Syndrome Be A Component Of Metabolic Syndrome?, Asi̇ye Kanbay, Tansu Ulukavak Çi̇ftçi̇, Oğuz Köktürk
Could Obstructive Sleep Apnea Syndrome Be A Component Of Metabolic Syndrome?, Asi̇ye Kanbay, Tansu Ulukavak Çi̇ftçi̇, Oğuz Köktürk
Turkish Journal of Medical Sciences
Aim: Obstructive sleep apnea syndrome (OSAS) is a prevalent disorder and is associated with increased cardiovascular morbidity and mortality. OSAS is independently related to the cardiovascular risk factors that comprise metabolic syndrome, atherosclerosis, acute coronary syndrome, and sudden death. The prevalence of metabolic syndrome is 30%-40% in the Turkish population. However, there are no data about the prevalence of metabolic syndrome (MS) in Turkish patients with OSAS. The aim of this study was to determine the prevalence of MS in Turkish patients with OSAS and MS-related cardiovascular diseases. Materials and Methods: The medical records of patients who were admitted to …
Effects Of Four Different Hormone Replacement Therapy Regimens On Certain Cardiovascular Risk Factors, Erdal Malatyalioğlu, Ari̇f Kökçü, Fi̇li̇z F. Yanik, Tayfun Alper
Effects Of Four Different Hormone Replacement Therapy Regimens On Certain Cardiovascular Risk Factors, Erdal Malatyalioğlu, Ari̇f Kökçü, Fi̇li̇z F. Yanik, Tayfun Alper
Turkish Journal of Medical Sciences
This study was performed to compare the effects of 4 different hormone replacement therapy (HRT) protocols on certain cardiovascular risk factors. Eighty- nine postmenopausal women were treated with oral conjugated estrogens, transdermal 17 beta-E2, cyclic oral E2-17- valerate+cyproterone acetate (E2-17-V+CA) or tibolone. Blood pressure (BP) measurements, fasting blood glucose (FBG), serum total cholesterol, low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL) and triglyceride levels at the 12th month were compared with the pretreatment values in each treatment group. There were no significant changes in the systolic BP, FBG, serum total and LDL-cholesterol levels in any group. Diastolic BP …